Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 4/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.51 |
| ▸ | MMP2 | P08253 | 4/20 | 0.51 |
| ▸ | MMP9 | P14780 | 3/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.51 |
| ▸ | ACE | P12821 | 1/20 | 0.50 |
| ▸ | CPA1 | P15085 | 1/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1921156 | 1.00 | MME (0.56) | MMENPSR1CYP1A2NAALAD2FOLH1 | |
| SCHEMBL1921155 | 1.00 | MME (0.56) | MMENPSR1CYP1A2NAALAD2FOLH1 | |
| SCHEMBL547710 | 0.87 | NAALAD2 (0.55) | MMENPSR1CYP1A2NAALAD2FOLH1 | |
| SCHEMBL547297 | 0.87 | NAALAD2 (0.55) | MMENPSR1CYP1A2NAALAD2FOLH1 | |
| SCHEMBL1272029 | 0.87 | NAALAD2 (0.55) | MMENPSR1CYP1A2NAALAD2FOLH1 | |
| SCHEMBL12207239 | 0.86 | MME (0.57) | MMENPSR1CYP1A2NAALAD2FOLH1 | |
| SCHEMBL7596254 | 0.86 | MME (0.57) | MMENPSR1CYP1A2NAALAD2FOLH1 | |
| SCHEMBL995917 | 0.85 | NPSR1 (0.55) | MMENPSR1CYP1A2NAALAD2FOLH1 | |
| SCHEMBL2214358 | 0.85 | FOLH1 (0.55) | MMENAALAD2FOLH1L3MBTL1ACE | |
| SCHEMBL5597679 | 0.85 | EPHX1 (0.51) | MMECYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024130161-A2 | NOVEL CAMPTOTHECIN DERIVATIVES AND CONJUGATES THEREOF | BIONECURE THERAPEUTICS INC (US) | 2024-06-20 | — | — | WO | disclosed |
| EP-4135738-A2 | METHOD OF TREATING CORONAVIRUS INFECTIONS | Cohbar Inc. (US) | 2023-02-22 | — | — | EP | disclosed |
| WO-2021211784-A2 | METHOD OF TREATING CORONAVIRUS INFECTIONS | COHBAR, INC. (US) | 2021-10-21 | — | — | WO | disclosed |